Amexdrug Corporation (AXRX)

Amexdrug Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jun 5, 2025	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Market Capitalization	0	8	17	17	19	9
Market Cap Growth	139.95%	-50.01%	-0.01%	-9.10%	115.38%	-15.00%
Enterprise Value	-	9	17	17	19	9
Last Close Price	0.00	0.05	0.10	0.10	0.11	0.05
PE Ratio	0.10	103.08	168.06	89.47	1014.33	700.61
PS Ratio	0.00	0.92	1.36	1.47	1.91	1.52
PB Ratio	0.03	19.68	48.52	67.53	292.58	158.41
P/TBV Ratio	0.03	20.56	51.26	73.00	416.76	243.90
P/FCF Ratio	-	-	-	75.94	-	-
P/OCF Ratio	-	-	-	74.59	-	-
EV/Sales Ratio	-	1.01	1.38	1.47	1.94	1.54
EV/EBITDA Ratio	-	42.99	74.98	56.72	296.36	173.55
EV/EBIT Ratio	-	47.28	77.15	58.30	340.21	262.81
EV/FCF Ratio	-	-	-	76.02	-	-
Debt / Equity Ratio	1.46	2.79	2.13	1.67	4.92	3.68
Debt / EBITDA Ratio	2.52	5.57	3.26	1.40	4.89	3.97
Debt / FCF Ratio	-	-	-	1.88	-	-
Asset Turnover	4.99	4.57	8.44	10.74	12.96	8.11
Inventory Turnover	11.76	16.30	45.43	45.56	48.98	25.80
Quick Ratio	0.67	0.60	1.00	0.85	0.79	0.64
Current Ratio	1.35	1.14	1.20	1.19	1.02	1.01
Return on Equity (ROE)	28.78%	21.08%	33.60%	120.38%	31.06%	25.49%
Return on Assets (ROA)	11.25%	6.11%	9.41%	16.96%	4.62%	2.97%
Return on Capital (ROIC)	16.75%	9.00%	15.72%	34.72%	11.02%	10.05%
Return on Capital Employed (ROCE)	34.40%	25.60%	63.50%	115.90%	87.60%	61.10%
Earnings Yield	980.63%	0.97%	0.60%	1.12%	0.10%	0.14%
FCF Yield	-3168.45%	-7.32%	-1.06%	1.32%	-0.39%	-2.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.